Polymerase Chain Reaction Market Report

Polymerase Chain Reaction Market Report, By Type (Conventional PCR, Real-Time PCR and Digital PCR), Product (Consumables and Reagents, Instruments and Software and Services), Application (Medical and Non-Medical), End Users (Hospitals and Clinics, Diagnostic Centers, Pharmaceutical and Biotechnology Industries, Academic and Research Organizations) and Geography – Global Market Share, Trend Analysis & Forecast , 2019 - 2028

Report Code : hc1955 | Publish Date : Upcoming | Industry : Healthcare | Geography : Global


MARKET OVERVIEW- GLOBAL POLYMERASE CHAIN REACTION MARKET

Polymerase chain reaction (PCR) devices, also known as thermocyclers, are commonly used in laboratories to amplify DNA segments through polymerase chain reactions. Cloning, DNA sequencing, library building, mutagenesis, and expression profiling are some of the key uses of PCR instruments.

Ongoing technological advancements in the field of polymerase chain reaction aim to improve the specificity, scalability and reliability of DNA amplification, thereby generating millions of amplicons of a target sequence in a short time span. PCR is used for a variety of applications, including the detection of pathogenic bacteria, disease diagnosis, molecular and genetic research, forensic DNA profiling, and parental testing. Rapid technological advances in the polymerase chain reaction to provide highly sensitive and optimized detection tools, the growing prevalence of chronic and infectious diseases, and increasing research funding in gene therapy and molecular testing are expected to fuel the growth of the global polymerase chain reaction market over the forecast period. Over the years, there has been a tremendous increase in research and development spending all over the world. This factor is anticipated to provide ample new growth opportunities for the market over the upcoming years. 

MARKET DRIVERS

The rising prevalence of chronic and infectious diseases and genetic disorders are important elements which are expected to drive demand for PCR technology over the forecast period. According to the CDC, chronic diseases such as cancer and diabetes, as well as chronic kidney and respiratory diseases such as asthma, are responsible for 7 out of 10 deaths in the United States each year. Moreover, the number of patients suffering from congenital heart disease is increasing, forcing medical professionals to seek molecular diagnostic tools for accurate diagnoses. According to the CDC, congenital heart defects are the most common birth defects in the United States, affecting approximately 1% of births each year. Thus, the increasing prevalence of diseases is expected to increase the demand for new molecular diagnostic tests during the forecast period.

The demand for genomic analysis techniques has grown steadily over the last decade due to their increasing use (microbial identification and detection of genetic mutations) in the diagnosis of major infectious diseases (such as tuberculosis, HIV, malaria, hepatitis, and staphylococcus) and genetic diseases (such as cancer and fragile X syndrome). In addition, the growing demand for point-of-care and self-testing tests is expected to drive the demand for polymerase chain reaction tests over the forecast period. Additionally, major market players are developing portable, fast and easy-to-use tools for point-of-care environments. This is expected to boost the growth of the market over the upcoming years.

MARKET OPPORTUNITIES

Technological advances in PCR testing in terms of sensitivity, accuracy, efficiency, and cost-effectiveness are expected to increase the acceptance of PCR testing in clinical diagnostics. The growing number of automated instruments and their easy availability are among the key factors expected to drive the market. Also, technological improvements and the subsequent introduction of affordable and highly effective products are expected to provide increasing new growth opportunities for the market over the forecast period. 

MARKET RESTRAINTS

PCR tests can be used for the analysis of various infections. However, the costs associated with using PCR enhancements for symptomatic testing are high. Patients, therefore, do not prefer to opt for such tests. Likewise, many countries do not grant refunds for these tests. Implementing these tariffs would result in reduced reimbursement for key molecular tests, including hereditary diseases, molecular cytogenetics, and cancer testing. Also, the lack of reimbursement option is further expected to restrict the growth of the polymerase chain reaction market over the forecast period.

MARKET GROWTH CHALLENGES

Lack of knowledge and awareness regarding polymerase chain reaction devices in emerging markets is expected to hamper the market’s growth. Also, a shortage of skilled healthcare professionals or a lack of trained experts is expected to challenge the growth of the polymerase chain reaction market over the forecast period.

ANALYSIS OF CUMULATIVE GROWTH

The report provides an in-depth analysis of the global Polymerase Chain Reaction market, market size, and compound annual growth rate (CAGR) for the forecast period of 2022-2028, considering 2021 as the base year. The increasing demand for polymerase chain reaction instruments in various applications has led to the increasing demand for the market and is expected to witness growth at a specific CAGR from 2021-2028.

hc1955-polymerase-chain-reaction-market-report

POLYMERASE CHAIN REACTION MARKET SEGMENTAL OVERVIEW

The global Polymerase Chain Reaction market comprises of different market segments like type, product, application, end users, and geography. 

POLYMERASE CHAIN REACTION MARKET BY TYPE 

By, the Polymerase Chain Reaction market includes the key segments of 
  • Conventional PCR
  • Real-Time PCR
  • Digital PCR
The real-time PCR segment is expected to hold the largest share of the global PCR market due to several factors, including advancements in technology, increasing use of real-time PCR in research and medical diagnosis, growing use of robotics for lab automation; and expanding the install base.
Digital PCR is expected to be the fastest growing segment in the polymerase chain reaction market, owing to factors such as the development of innovative digital PCR products, increased government and private funding for genetic research, and  strong growth opportunities in emerging markets.
The conventional PCR segment is expected to experience significant growth over the forecast period. The growth of conventional PCR is fuelled by the increasing adoption of conventional PCR in food testing and safety and by an increase in product launches.

POLYMERASE CHAIN REACTION MARKET BY PRODUCT

By product, the Polymerase Chain Reaction market is segmented into 
  • Consumables and Reagents
  • Instruments
  • Software and Services
The consumables and reagents segment is expected to maintain its dominance over the forecast period. The growth of the segment can be attributed to the increased burden of infectious and chronic diseases, the increased demand for consumables and reagents in various types of diagnostic tests, and the increase in product launches.
Due to the high penetration of PCR equipment in central laboratories and the increasing adoption of technologically advanced equipment in recent years, the instrument segment is expected to record the second highest growth rate over the estimated time period. The software and hardware segment services is expected to witness the fastest growth rate over the forecast period due to increasing strategic collaborations to develop and advance software.

POLYMERASE CHAIN REACTION MARKET BY APPLICATION

The Polymerase Chain Reaction market has major applications in  
  • Medical
  • Non- Medical
The medical application segment is further segmented into clinical, research, forensics, and others. The clinical section is further sub-segmented into pathology testing, oncology testing, blood
screening, and others. The non-medical application segmented is further segment into food, agriculture, and others.
The medical segment is expected to lead the market due to the high adoption rate of PCR tests for clinical diagnostics and research activities for the study of diseases and drug development. Furthermore, the increasing use of PCR in the detection of SARS-CoV-2 infections and in drug development and research activities is increasing the demand for testing. In addition, the high accuracy of the test methods, the growing commercialization of real-time PCR and digital PCR reagents for diagnostics, and the growing applications for disease diagnosis, monitoring, and treatment are driving the growth of the market.
The non-medical applications segment is expected to grow at the fastest growth rate over the forecast period. The increasing adoption of PCR techniques to test food and other consumables is expected to drive the segment during the forecast period. The food industry is applying new and reliable tests to reduce the risk of contamination and improve food safety.

POLYMERASE CHAIN REACTION MARKET BY END USERS

The Polymerase Chain Reaction market has major end users like 
  • Hospitals and Clinics
  • Diagnostic Centers
  • Pharmaceutical and Biotechnology Industries
  • Academic & Research Organizations
  • Others
The pharmaceutical and biotechnology industry segment is anticipated to grow impressively over the forecast period.
The polymerase chain reaction (PCR) approach has proven effective in pharmaceutical and biotechnology research and microbiological quality control. Additionally, the approach is used in genetic engineering. Genetic engineering is the major driver of the global polymerase chain reaction (PCR) market. It is used to discover genes associated with specific phenotypes, such as genetic diseases. Regular screening of raw materials and finished products for microbial contamination is an essential practice in the pharmaceutical and biotechnology industries. In the pharmaceutical industry, sophisticated analytical methods such as polymerase chain reaction (PCR) are often used for quality control.
Likewise, hospitals and clinics, followed by diagnostic centers, are expected to grow at a significantly high rate over the projection period. Real-time PCR tests are being used at a high rate since the outbreak of COVID-19. It is an important test for the diagnosis of SARS-CoV-2 virus, and is being used extensively in hospitals and clinics as well as in diagnostic centers. These factors are anticipated to contribute to the growth of the segment over the forecast period. 

POLYMERASE CHAIN REACTION MARKET BY GEOGRAPHY

The global Polymerase Chain Reaction market is studied for the following region 
  • North America
  • Europe
  • Asia-Pacific
  • Rest of the world (RoW)
North America is expected to hold the largest share of revenue over the forecast period. The presence of favourable regulations and various initiatives by the government on the advancement of health infrastructure, the high prevalence of diseases, and the presence of key players in the region are supporting the growth of the regional market. Furthermore, the growing awareness of patients regarding the availability of modern products for successful diagnosis is another factor contributing to its growth.
The Asia-Pacific is projected to grow at a high rate over the projected time period. Untapped opportunities, high unmet clinical needs, and rising healthcare spending by Asia-Pacific countries are encouraging global players to invest in the region. Furthermore, the increasing prevalence of various target diseases and technological advances are likely to increase the demand for PCR during the forecast period. Furthermore, the launch of products by local players in new markets to strengthen their presence is expected to drive the growth of the market.

COVID-19 IMPACT ANALYSIS ON GLOBAL POLYMERASE CHAIN REACTION MARKET

Axiom MRC provides a 360 degree analysis of micro and macro-economic factors on the global Polymerase Chain Reaction market. In addition, the exclusive report provides a complete analysis of changes in the global Polymerase Chain Reaction market, including expenditure, economic and international policies on the supply and demand side. The report also studies the impact of the pandemic on global economies, international trade, business investments, GDP, and marketing strategies of key players present in the market. 
The COVID-19 pandemic has positively impacted the global polymerase chain reaction market due to the application of the polymerase chain reaction technique to detect COVID-19. For example, in January 2020, according to data published by PubMed, zoonotic transmission of SARS coronavirus from animals to humans was detected using standard reverse transcription polymerase chain reaction (RT-PCR) assays targeting a highly conserved sequence among coronaviruses. Reverse transcription polymerase chain reaction (RT-PCR) tests were first used to identify coronaviruses in bats. The development of new real-time PCR tests to detect SARS-CoV-2 infection and the increase in research and development activities to study the disease have led to the introduction of technologically advanced PCR tests to the market.

COMPETITIVE LANDSCAPE ANALYSIS

The competitive landscape analysis of the Polymerase Chain Reaction market is majorly focused on expanding the global growth of Polymerase Chain Reaction with new product innovation, business expansion, and the increasing presence of a range of manufacturers operating in the polymerase chain reaction instruments industry has led to the growing demand for the market.  Besides, the market offers a range of products in different applications to fulfil the required demand of consumer which is further contributing to healthy growth in the market.  
The key players studied in market are 
  • Bio-Rad Laboratories, Inc
  • Abbott
  • Siemens Healthcare GmbH
  • QIAGEN N.V.
  • F. Hoffmann-La Roche AG
  • Thermo Fisher Scientific, Inc.
  • Agilent Technologies, Inc.
  • Danaher
  • Becton, Dickinson and Company
  • Johnson & Johnson Private Limited 
  • BioMerieux S.A
  • Merck KGaA
  • Stryker
  • Fluidigm
  • Cytiva
  • Smith & Nephew plc

RECENT DEVELOPMENT:

October 2021: Thermo Fisher Scientific, provider of scientific instrumentation, reagents, and consumables, has introduced the Applied Biosystem QuantStudio Absolute Q-Digital PCR System, the first fully integrated digital PCR (dPCR) system designed to provide highly accurate and consistent results in genetic analysis and research within 90 minutes.
March 2021: Agilent Technologies Inc., announced the launch of a real-time reverse transcription (qRT) PCR-based diagnostic kit for the detection of SARS-CoV-2 RNA. The CE-IVD mark is in accordance with the European Union In-Vitro Diagnostic Directive 98/79/EC and has been made available for immediate distribution.

POLYMERASE CHAIN REACTION MARKET SUMMARY

By type, the Polymerase Chain Reaction market includes the key segments of conventional PCR, real-time PCR, and digital PCR. The real-time PCR segment is expected to dominate the market over the forecast period. By product, the Polymerase Chain Reaction market includes the key segments of consumables and reagents, instruments, software, and services. The consumables and reagents segment is expected to maintain its dominance over the forecast period.

The Polymerase Chain Reaction market has major applications in the medical and non-medical sectors. The medical application segment is further segmented into clinical, research, forensics, and others. The clinical section is further sub-segmented into pathology testing, oncology testing, blood screening and others. The non-medical application segment is further segmented into food, agriculture, and others. The medical segment is expected to lead the market due to the high adoption rate of PCR tests for clinical diagnostics and research activities for the study of diseases and drug development. The Polymerase Chain Reaction market has major end users like hospitals and clinics, diagnostic centers, pharmaceutical and biotechnology industries, academic and research organizations, and others. The pharmaceutical and biotechnology industry segment is anticipated to grow at a high rate over the forecast period. The global Polymerase Chain Reaction market is studied for the following regions: North America, Europe, Asia-Pacific, and Rest of the World (RoW). North America is expected to hold the largest share of revenue over the forecast period.

SCOPE OF THE REPORT:

Market Sizing for Year:
2019-2028
Base Year:
2021
Forecast Period:
2022-2028
Value:
USD million
Market Segment studied:

Type

Product

Application

End Users

Geography
Market Players and its Competitors:

Bio-Rad Laboratories, Inc

Abbott

Siemens Healthcare GmbH

QIAGEN N.V.

F. Hoffmann-La Roche AG

Thermo Fisher Scientific, Inc.

 Agilent Technologies, Inc.

Danaher

Becton, Dickinson and Company

Johnson & Johnson Private Limited 

BioMerieux S.A

Merck KGaA

Stryker

Fluidigm

Cytiva

Smith & Nephew plc

FREQUENTLY ASKED QUESTIONS

What would be forecast period in the market report?

2022-2088 is the forecast period in the market report.

Which is the leading application segment for Polymerase Chain Reaction market?

The medical segment has accounted the major market share, and is expected to witness the growth at highest pace during the forecast period.

Which region is gaining majority of market share during the forecast period (2022-2028)?

North America is expected to gain major market share during the forecast period (2022-2028).